BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15869878)

  • 1. Biaryl isoxazolinone antibacterial agents.
    Quesnelle CA; Gill P; Roy S; Dodier M; Marinier A; Martel A; Snyder LB; D'Andrea SV; Bronson JJ; Frosco M; Beaulieu D; Warr GA; Denbleyker KL; Stickle TM; Yang H; Chaniewski SE; Ferraro CA; Taylor D; Russell JW; Santone KS; Clarke J; Drain RL; Knipe JO; Mosure K; Barrett JF
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2728-33. PubMed ID: 15869878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials.
    Snyder LB; Meng Z; Mate R; D'Andrea SV; Marinier A; Quesnelle CA; Gill P; DenBleyker KL; Fung-Tomc JC; Frosco M; Martel A; Barrett JF; Bronson JJ
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4735-9. PubMed ID: 15324898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens.
    Barbachyn MR; Cleek GJ; Dolak LA; Garmon SA; Morris J; Seest EP; Thomas RC; Toops DS; Watt W; Wishka DG; Ford CW; Zurenko GE; Hamel JC; Schaadt RD; Stapert D; Yagi BH; Adams WJ; Friis JM; Slatter JG; Sams JP; Oien NL; Zaya MJ; Wienkers LC; Wynalda MA
    J Med Chem; 2003 Jan; 46(2):284-302. PubMed ID: 12519066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship studies of highly potent novel oxazolidinone antibacterials.
    Komine T; Kojima A; Asahina Y; Saito T; Takano H; Shibue T; Fukuda Y
    J Med Chem; 2008 Oct; 51(20):6558-62. PubMed ID: 18826297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
    Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
    J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens.
    Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3556-61. PubMed ID: 18511280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-antibacterial activity of arylcarbonyl- and arylsulfonyl-piperazine 5-triazolylmethyl oxazolidinones.
    Phillips OA; Udo EE; Ali AA; Samuel SM
    Eur J Med Chem; 2007 Feb; 42(2):214-25. PubMed ID: 17140706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
    Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
    Liu J; Cao R; Wu Q; Ma C; Wang Z; Peng W; Song H
    Eur J Med Chem; 2009 Apr; 44(4):1737-44. PubMed ID: 18450331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
    Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides.
    Beebe X; Yang F; Bui MH; Mitten MJ; Ma Z; Nilius AM; Djuric SW
    Bioorg Med Chem Lett; 2004 May; 14(10):2417-21. PubMed ID: 15109624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against Gram-positive bacteria.
    Liu J; He B; Yu A; Zhou W
    Chem Biol Drug Des; 2007 Apr; 69(4):265-8. PubMed ID: 17461974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
    Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
    Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antibacterial activity of 6-O-arylbutynyl ketolides with improved activity against some key erythromycin-resistant pathogens.
    Keyes RF; Carter JJ; Englund EE; Daly MM; Stone GG; Nilius AM; Ma Z
    J Med Chem; 2003 May; 46(10):1795-8. PubMed ID: 12723941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial activity of a new series of 3-[3-(substituted phenyl)-1-isonicotinoyl-1H-pyrazol-5-yl]-2H-chromen-2-one derivatives.
    Aragade P; Maddi V; Khode S; Palkar M; Ronad P; Mamledesai S; Satyanarayana D
    Arch Pharm (Weinheim); 2009 Jun; 342(6):361-6. PubMed ID: 19475595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in the discovery of novel oxazolidinone antibacterials.
    Gravestock MB
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):469-77. PubMed ID: 16022183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in the identification of novel oxazolidinone antibacterial agents.
    Renslo AR; Luehr GW; Gordeev MF
    Bioorg Med Chem; 2006 Jun; 14(12):4227-40. PubMed ID: 16527486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics.
    Zhou J; Bhattacharjee A; Chen S; Chen Y; Duffy E; Farmer J; Goldberg J; Hanselmann R; Ippolito JA; Lou R; Orbin A; Oyelere A; Salvino J; Springer D; Tran J; Wang D; Wu Y; Johnson G
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6175-8. PubMed ID: 18947996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking inventory: antibacterial agents currently at or beyond phase 1.
    Bush K; Macielag M; Weidner-Wells M
    Curr Opin Microbiol; 2004 Oct; 7(5):466-76. PubMed ID: 15451501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
    CalĂ­ P; Naerum L; Mukhija S; Hjelmencrantz A
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.